Contact Person : Marisa Reschman; Last Date for the submission of abstract : Not Available ; Description : Five-year survival for patients with NSCLC is currently only 15%, largely due to the fact that only approximately half of these patients have surgically resectable disease. Furthermore, among those who can be surgically treated, less than